Alembic Pharma gets USFDA nod for cholesterol lowering drug

The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Fenofibrate tablets in the strengths of 48 mg and 145 mg, Alembic Pharmaceuticals said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2ZYDTOd